Nalcntm2(EGFP/cre/ERT2)Wtsi
Targeted Allele Detail
|
Symbol: |
Nalcntm2(EGFP/cre/ERT2)Wtsi |
Name: |
sodium leak channel, non-selective; targeted mutation 2, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:5633812 |
Synonyms: |
Nalcntm2(EGFP/cre/ERT2)Hmgu |
Gene: |
Nalcn Location: Chr14:123514046-123864556 bp, - strand Genetic Position: Chr14, 66.04 cM
|
Alliance: |
Nalcntm2(EGFP/cre/ERT2)Wtsi page
|
|
Mutant Cell Line: |
CEPD0086_2_G06 |
Germline Transmission: |
Earliest citation of germline transmission:
J:204812
|
Parent Cell Line: |
JM8.N4 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
Project Collection: |
EUCOMMTOOLS
|
|
Allele Type: |
|
Targeted (Inducible, Recombinase, Reporter) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Nalcntm2(EGFP/cre/ERT2)Wtsi expression driven by
1 gene
Knock-in expression driven by:
|
|
|
Mutation details: According to the allele molecular image presented by the International Knockout Mouse Consortium, this allele has one FRT site, an engrailed 2 splice acceptor sequence, an EGFP and cre/ERT2 expression cassette, and a neomycin resistance cassette inserted in the intron between exons 4 and 5. A single loxP site is inserted in intron 6.
(J:155845)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Nalcn
(mouse)
|
|
|
|
|
Original: |
J:155845 Wellcome Trust Sanger Institute, Alleles produced for the EUCOMM and EUCOMMTools projects by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2010; |
All: |
2 reference(s) |
|